Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/9/2021 | Underperform → Market Perform | Raymond James | |
| 8/26/2021 | $6.00 → $6.50 | Underweight | Wells Fargo |
4 - PROSPECT CAPITAL CORP (0001287032) (Issuer)
4 - PROSPECT CAPITAL CORP (0001287032) (Issuer)
4 - PROSPECT CAPITAL CORP (0001287032) (Issuer)
Catalent, Inc. (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced the appointment of Joseph A. Ferraro as Senior Vice President, General Counsel, Chief Compliance Officer, and Secretary. Mr. Ferraro will be responsible for managing Catalent's global legal and compliance operations. He will be based at the company's headquarters in Somerset, New Jersey, head up the company's Legal Leadership Team, and serve on its Executive Leadership Team, reporting directly to Catalent's Executive Vice President and Chief Administrative Officer, Steven Fasman. This press release features multimedia. View the full release here: https:/
SC 13D/A - PROSPECT CAPITAL CORP (0001287032) (Subject)
SC 13D/A - PROSPECT CAPITAL CORP (0001287032) (Subject)
8-K - PROSPECT CAPITAL CORP (0001287032) (Filer)
10-Q - PROSPECT CAPITAL CORP (0001287032) (Filer)
POS EX - PROSPECT CAPITAL CORP (0001287032) (Filer)
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Prospect Capital Management L.P. ("Prospect"), investment adviser to Prospect Capital Corporation (NASDAQ:PSEC) and other funds, announced today that Prospect has received an Honorable Mention in Mergers & Acquisitions' 2025 Middle-Market Deals of the Year Awards for Prospect's role in providing value-added capital to Druid City Infusion ("Druid City"). The recognition highlights Prospect's role as a significant capital provider and lender in the transaction, which is the first time a franchise within the Vital Care network received institutional capital. Vital Care is the nation's largest home infusion franchise platform, with over 160 locations
NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (NASDAQ:PSEC) (the "Company" or "Prospect") today announced it expects to file with the Securities and Exchange Commission its report on Form 10-Q containing results for the fiscal quarter ended March 31, 2025 on Thursday, May 8, 2025. The Company also expects to issue its earnings press release on Thursday, May 8, 2025, after the close of the markets. The Company will host a conference call on Friday, May 9, 2025 at 9:00 a.m. Eastern Time. The conference call dial-in number will be 888-338-7333. A recording of the conference call will be available for approximately 30 days. To hear a replay, call 877-344-7529 and use
NEW YORK, April 18, 2025 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (the "Company") today announced the results of its previously announced cash tender offer (the "Tender Offer") to purchase any and all of the outstanding notes listed below. The Tender Offer was made pursuant to an Offer to Purchase dated April 9, 2025 (the "Offer to Purchase"), which set forth the terms and conditions of the Tender Offer, and the accompanying notice of guaranteed delivery (the "Notice of Guaranteed Delivery"). As of the previously announced expiration time of 5:00 p.m., New York City time, on April 17, 2025 (the "Expiration Time"), according to information provided by D.F. King & Co., Inc., the Inf
4 - PROSPECT CAPITAL CORP (0001287032) (Issuer)
4 - PROSPECT CAPITAL CORP (0001287032) (Issuer)
4 - PROSPECT CAPITAL CORP (0001287032) (Issuer)
Raymond James upgraded Prospect Capital from Underperform to Market Perform
Wells Fargo reiterated coverage of Prospect Capital with a rating of Underweight and set a new price target of $6.50 from $6.00 previously
Wells Fargo reiterated coverage of Prospect Capital with a rating of Underweight and set a new price target of $6.00 from $5.75 previously
NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (NASDAQ:PSEC) (the "Company" or "Prospect") today announced it expects to file with the Securities and Exchange Commission its report on Form 10-Q containing results for the fiscal quarter ended March 31, 2025 on Thursday, May 8, 2025. The Company also expects to issue its earnings press release on Thursday, May 8, 2025, after the close of the markets. The Company will host a conference call on Friday, May 9, 2025 at 9:00 a.m. Eastern Time. The conference call dial-in number will be 888-338-7333. A recording of the conference call will be available for approximately 30 days. To hear a replay, call 877-344-7529 and use
NEW YORK, March 11, 2025 (GLOBE NEWSWIRE) -- Priority Income Fund, Inc. ("Priority Income Fund" or the "Fund") announced today that the Fund's Board of Directors has declared distributions on shares of the Fund's 7.00% Series D Term Preferred Stock due 2029 ("Series D"), 6.625% Series F Term Preferred Stock due 2027 ("Series F"), 6.000% Series H Term Preferred Stock due 2026 ("Series H"), 6.125% Series I Term Preferred Stock due 2028 ("Series I"), 6.000% Series J Term Preferred Stock due 2028 ("Series J"), 7.000% Series K Cumulative Preferred Stock ("Series K"), and 6.375% Series L Term Preferred Stock due 2029 ("Series L"). Ex-Dividend DateRecord DatePayable DateDistribution per ShareSer
NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) -- Priority Income Fund, Inc. ("Priority Income Fund" or the "Fund") announced today that it will redeem all outstanding shares of its 6.000% Series H Term Preferred Stock Due 2026 ((CUSIP: 74274W 798, NYSE:PRIF) (the "Series H Preferred Shares") at a price of $25 per Series H Preferred Share, plus accrued but unpaid dividends per Series H Preferred Share from March 31, 2025, to but excluding, the Redemption Date (the "Redemption Price"). The redemption date will be April 9, 2025 (the "Redemption Date"). On the Redemption Date, the Redemption Price will become due and payable on the Series H Preferred Shares and any dividends shall cease to accumu